A newly identified autosomal dominant human disorder has familiar clinical features.
Neurofibromatosis type 1 (NF1) is an autosomal dominant disorder characterized by multiple café-au-lait macules (CALMs), soft cutaneous neurofibromas, axillary freckling, Lisch nodules, and other, rarer internal malignancies. NF1 is caused by inactivating mutations in neurofibromin (encoded by the NF1 gene), a negative regulator of RAS signaling.
Investigators in Belgium recently identified five families with NF1-like phenotypes, including multiple CALMs, axillary freckling, macrocephaly, and a Noonan syndrome–like dysmorphology. Molecular analysis of NF1 and linkage analysis of the families excluded NF1 as the causative gene. A genome-wide scan detected a possible locus on chromosome 15 in a region encompassing the SPRED1 gene. Sequence ana…
Reviewing Author
DisclosuresConsultant / advisory board Lubax; WorldCare Clinical
EquityLubax
Grant / Research support NIH; Department of Defense; American Skin Association; Piramal
Editorial boardsBritish Journal of Dermatology; Journal of the American Academy of Dermatology; Journal of Investigative Dermatology
Leadership positions in professional societies American Academy of Dermatology (Chair, Skin Cancer and Melanoma Committee); American Board of Dermatology (Director)
DisclosuresConsultant / advisory board Lubax; WorldCare Clinical
EquityLubax
Grant / Research support NIH; Department of Defense; American Skin Association; Piramal
Editorial boardsBritish Journal of Dermatology; Journal of the American Academy of Dermatology; Journal of Investigative Dermatology
Leadership positions in professional societies American Academy of Dermatology (Chair, Skin Cancer and Melanoma Committee); American Board of Dermatology (Director)